Showing 1661-1670 of 2652 results for "".
- Fifteenth Annual Eyes on Capitol Hill Advocacy Eventhttps://modernod.com/news/fifteenth-annual-eyes-on-capitol-hill-advocacy-event/2477302/Prevent Blindness will be holding its 15th annual “Eyes on Capitol Hill” advocacy day on February 26, 2020, in Washington, D.C. The annual program provides those from across the United States the opportunity to meet with Congressional and Senate members, and their staff, to discuss vision issues
- Alcon Showcases New Vitrectomy Probe and Next Generation Ngenuity 3D Visualization System at ASRShttps://modernod.com/news/alcon-showcases-new-vitrectomy-probe-and-nextgeneration-ngenuity-3d-visualization-system-at-asrs/2476772/Alcon is introducing the Hypervit Dual Blade Vitrectomy Probe, the newest addition to the Constellation Vision System, at the American Society of Retina Specialists (ASRS) 2019 annual meeting taking place July 26-30 in Chicago. The company is also featuring its next generation Ngenuity 3D Visuali
- Clearside Biomedical Announces Multiple Oral Presentations to be Given at the ASRS Annual Meetinghttps://modernod.com/news/clearside-biomedical-announces-multiple-oral-presentations-to-be-given-at-the-asrs-annual-meeting/2476742/Clearside Biomedical announced that multiple oral presentations on Clearside’s pipeline and proprietary SCS Microinjector targeting the suprachoroidal space will be given at the upcoming American Society of Retinal Specialists (ASRS) annual meeting taking place July 26-30, 2019 in Chicago. <
- Bausch + Lomb Announces New Scientific Analyses Featuring Surgical And Pharmaceutical Products Will Be Presented During ASCRShttps://modernod.com/news/bausch-lomb-announces-new-scientific-analyses-featuring-surgical-and-pharmaceutical-products-will-be-presented-during-ascrs/2476509/Bausch + Lomb announced that 26 new scientific analyses, including 23 podium presentations and three posters, will feature the company’s surgical and pharmaceutical products during the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting in San Diego from
- Johnson & Johnson Vision to Showcase New Products, Data, Educational Opportunities, and Charitable Giving at 2018 AAOhttps://modernod.com/news/johnson-johnson-vision-to-showcase-new-products-data-educational-opportunities-and-charitable-giving-at-2018-aao/2479756/Johnson & Johnson Vision will showcase the company’s leadership in eye health, innovation and giving at the 2018 American Academy of Ophthalmology’s Annual Meeting (AAO) in Chicago, October 26-30. Johnson & Johnson Vision invented many of the treatments changing the trajectory of e
- Ellex to Host an AMD Roundtable During AAO 2018https://modernod.com/news/ellex-to-host-an-amd-roundtable-during-aao-2018/2479760/Ellex Medical Lasers Limited announced that it will partner with a panel of leading ophthalmologists to host a roundtable on age-related macular degeneration (AMD) on Friday, October 26, during the American Academy of Ophthalmology (AAO) meeting in Chicago. “Our goal is to start a serious
- Diopsys Highlights Educational Initiatives For ESCRS 2018https://modernod.com/news/diopsys-highlights-educational-initiatives-for-escrs-2018/2479883/Diopsys announced educational initiatives for the ESCRS 2018 Congress in Vienna, Austria, September 22-26. In addition to presentations that highlight how the various forms of testing available on Diopsys devices add to the management of eye care patients, the company will also be introducing the
- Aerpio Pharmaceuticals Announces Uplisting to Nasdaq Capital Market and Pricing of $45 Million Public Offering of Common Stockhttps://modernod.com/news/aerpio-pharmaceuticals-announces-uplisting-to-nasdaq-capital-market-and-pricing-of-45-million-public-offering-of-common-stock/2480066/Aerpio Pharmaceuticals announced that its common stock will begin trading on the Nasdaq Capital Market under the symbol “ARPO” at the opening of trading on June 26, 2018, following its previously announced approval to list its common stock on the Nasdaq Capital Market. Aerpio also announce
- Why Johnson & Johnson is Investing in This Niche Telehealth Startuphttps://modernod.com/news/why-johnson-johnson-is-investing-in-this-niche-telehealth-startup/2478171/Pharmaceutical giant Johnson & Johnson is investing in direct-to-consumer telehealth company Thirty Madison. New York City-based Thirty Madison offers telehealth visits and online prescriptions for drugs for hair loss, migraines and acid reflux, according to a FierceHealthcare
- Chiropractic Treatment and Vision Loss: Examining the Connectionhttps://modernod.com/news/chiropractic-treatment-and-vision-loss-examining-the-connection/2479828/Many Americans visit chiropractors to address pain, often without informing their physicians. And they might not consider eye complications that could result, says Yannis Paulus, MD, a retina specialist at the University of Michigan Kellogg Eye Center. The energetic thrusts and rota